Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/2003
08/13/2003CN1436076A Method of treating cardiovascular disease
08/13/2003CN1436075A Gabapentin analogues for sleep disorders
08/13/2003CN1436073A Management of snoring by oral administration of dimethyl sulfone
08/13/2003CN1436072A Composition, kits, and methods for promoting defined health benefits
08/13/2003CN1436048A Infant formulas contg. long-chain polyunsaturated fatty acids and uses thereof
08/13/2003CN1436047A Compositions and methods for improving vascular health
08/13/2003CN1435429A Buxanines compounds with cardiovascular activity and cardiovascular and cerebrovascular medicine using them as active component
08/13/2003CN1435428A Cyclovirobuxine D salt and its preparation and use, and process for preparing said preparation
08/13/2003CN1435420A Crystalline form of Adefovir dipivoxil and preparing process thereof
08/13/2003CN1435418A Aromatic nitrogen-contg. bis-phosphonic acid derivs., process for preparing same and use thereof
08/13/2003CN1435261A Thermosetting medical carrier composition with mucosa adsorption
08/13/2003CN1435186A Use of refined fur seal oil for preparing medicine for preventing and treating senile dementia and apoplexy sequela
08/13/2003CN1435185A Cell growth regulatory factor A and preparing process thereof
08/13/2003CN1435184A Cell growth regulatory factor C and preparing process thereof
08/13/2003CN1435183A Cell growth regulatory factor L and preparing process thereof
08/13/2003CN1435182A Cell growth regulatory factor N and preparing process thereof
08/13/2003CN1435181A Use of Onychium japonicum extract for preparing medicine of preventing and treating cardiovascular diseases
08/13/2003CN1435180A Gypenoside drip pill, and preparing process thereof
08/13/2003CN1435179A Biologic converted ginseng composition and preparing process thereof
08/13/2003CN1435178A Osmosis pump controlled release preparation contg. Chinese medicine of cyclovirobuxine D, and preparing method thereof
08/13/2003CN1435177A Antibacterial combined medicine
08/13/2003CN1435176A Triclabendazole-contg. preparation based on surfactant
08/13/2003CN1435175A Chinese medicinal preparation contg. lysiontus pauciflorus extract, process for preparing same and use thereof
08/13/2003CN1435174A Externally used urotropin nebula and preparing method thereof
08/13/2003CN1435167A Carboplatin precursor liposome injection and preparing process thereof
08/13/2003CN1435095A Synergic microbiocidal composition
08/13/2003CN1117760C Lysosomal enzyme-cleavable antitumor drug conjugates
08/13/2003CN1117759C Steroid, its preparation method, medicine composition and use thereof
08/13/2003CN1117755C Spiroazabicyclic heterocyclic compounds, method for preparing same and use thereof
08/13/2003CN1117753C Substd. benzimidazoles, production and use thereof as agents for combating parasitic protozoas
08/13/2003CN1117752C Method for purifying and crystallizing vitamin B2
08/13/2003CN1117751C Antiviral nucleoside analogues
08/13/2003CN1117746C Method for preparing substd. pyridines and pyridines obtained thereby
08/13/2003CN1117745C Noval tricyclic N-cyanoimines useful as inhibitors of farnesyl-protein transferase
08/13/2003CN1117744C 1-(1,2-disubstd. piperidinyl)-4-substd. piperazine derivs.
08/13/2003CN1117738C Endothelin antagonists
08/13/2003CN1117732C Noval Dihydronaphthalene compound and process for producing same
08/13/2003CN1117585C Nisin in combination with glycerol monolaurate active against helicobacterium
08/13/2003CN1117579C Plaster for treating common cold
08/13/2003CN1117572C Medicine powder for treating athlete's foot, smelly foot and sweaty foot
08/13/2003CN1117571C Improved calcium dietary supplement
08/13/2003CN1117570C Ointment for external use
08/13/2003CN1117569C Bicyclic fibrinogen antagonists
08/13/2003CN1117568C Gastrokinetic bicyclie benzamides of 3-or 4-substd. 4-(aminomethyl)-piperidine derivs.
08/13/2003CN1117567C Paroxetine controlled release compositions
08/13/2003CN1117566C Combination therapy comprising amlodipine and statin compound
08/13/2003CN1117565C Stable anti-racemic medicinal preparation of cilancetlone
08/13/2003CN1117564C Use of prumipexole in treating of restless legs syndrome
08/13/2003CN1117563C Analgesic composition for cancer in digestive system
08/13/2003CN1117562C Compositions and method for controlling smoking
08/13/2003CN1117561C Compounded calcium preparation, preparing method and use thereof
08/13/2003CN1117560C Reflux inhibitors
08/13/2003CN1117528C Nutritional product for person having renal failure
08/12/2003US6605742 Rheumatic diseases; antiarthritic agents; antitumor agents
08/12/2003US6605730 3-(2-Thienyl)-5-phenyl-1H-pyrazole compounds of given formula
08/12/2003US6605729 Crystalline forms of [R-(R*,R*)]-2-(4-fluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid calcium salt (2:1)
08/12/2003US6605725 Treating a central or peripheral nervous system disorder or condition through modulation of a voltage-dependent potassium channel
08/12/2003US6605723 Process for the preparation of ethanesul fonyl-piperidine derivatives
08/12/2003US6605722 Tyrosine derivatives with anti-leukotrienen activity
08/12/2003US6605713 Contacting D-nucleic acids with a racemic mixture of the target molecule and allow for binding; producing L-nucleic acids; in vitro selection of DNA/RNA with high binding affinity and stability
08/12/2003US6605712 Isolated DNA comprising a radiation inducible promoter linked to a region encoding a polypeptide; use for regulating polypeptide expression and inhibiting tumor growth; anticarcinogenic agent
08/12/2003US6605698 Antifungal peptides and composition thereof
08/12/2003US6605646 Vitamin supplement composition
08/12/2003US6605645 Such as 1,15-di(cyclopropylmethylamino)-8-benzyl-4,8,12-triazapentadecane; carcinostatic action
08/12/2003US6605644 Analgesic regimen
08/12/2003US6605642 Inhibitors of formation of advanced glycation endproducts (AGES)
08/12/2003US6605641 20-HETE antagonists and agonists
08/12/2003US6605640 Treating a retinal or choroidal vascular or hereditary disease by topically administering an acetylcholine esterase inhibitor, e.g., Phospholine Iodide; age related macular degeneration disease; diabetic retinopathy
08/12/2003US6605639 Treating and/or preventing diseases alleviated by retinoid X receptor ligand dependent transcriptional regulation using ascochlorin or derivatives
08/12/2003US6605638 Treating multidrug resistant tumors; increasing drug bioavailability
08/12/2003US6605637 Lipoic acid derivatives, their preparation, and pharmaceutical compositions containing them
08/12/2003US6605636 Atorvastatin hemi-calcium form VII
08/12/2003US6605635 N-substituted benzyl or phenyl aromatic sulfamides compounds and the use thereof
08/12/2003US6605634 Aryl and heteroaryl substituted fused pyrrole anti-inflammatory agents
08/12/2003US6605633 Such as 5-Bromo-2-phenyl-1H-indole-3-butanoic acid
08/12/2003US6605632 Affinity for melatonin receptors
08/12/2003US6605630 Active against drug resistant gram positive pathogens
08/12/2003US6605629 Oxazole derivatives; low toxicity
08/12/2003US6605628 Method of using 5-(arysulfonyl)-, 5-(arylsulfanyl)-and 5-(arylsulfanyl)thiazolidine-2,4-diones for inhibition of farnesyl-protein transferase
08/12/2003US6605627 Modulators of peroxisome proliferator activated receptor-gamma, and methods for the use thereof
08/12/2003US6605626 Antithrombotic agents
08/12/2003US6605625 Antiarrhythmia agents
08/12/2003US6605624 Substituted pyridines useful for inhibiting cholesteryl ester transfer protein activity
08/12/2003US6605622 Use of anti-estrogenic compounds as anti-fungal agents
08/12/2003US6605621 Monomeric and dimeric heterocycles, and therapeutic uses thereof
08/12/2003US6605619 Treating or preventing damage to normal cells, tissues or organs in exposed to ionizing radiation
08/12/2003US6605617 Treating a patient in need of an inhibitor of vascular endothelial growth factor receptor tyrosine kinase
08/12/2003US6605613 Polyene macrolide antibiotic, especially a rapamycin, and an antioxidant, especially 2,6-di-t-butyl-4-methylphenol; 40-O-(2-hydroxy)ethyl-rapamycin in crystalline form.
08/12/2003US6605612 Cardioprotective phosohonates and malonates
08/12/2003US6605611 Nucleoside and nucleotide analogues labelled with a reporter moiety
08/12/2003US6605610 Aryl fused azapolycyclic compounds
08/12/2003US6605609 N-(((5S)-3-(4-(1,1-dioxido-4-thiomorpholinyl)-3,5-difluorophen yl) -2-oxo-1,3-oxazolidin-5-yl)methyl)acetamide antimicrobial used in combination therapy
08/12/2003US6605608 Amino acid derivatives and drugs containing the same as the active ingredient
08/12/2003US6605607 Antihypertensives; hyperprolactinaemia related conditions; certain central nervous system disorders
08/12/2003US6605606 Solid forms of tin ethyl etiopurpurin and processes for producing such forms
08/12/2003US6605605 Estrogenic substances combined with cruciferous indole compounds
08/12/2003US6605604 Carboxylic and hydroxamic acid compounds inhibiting metalloproteases, method for preparing same and pharmaceutical compositions containing them
08/12/2003US6605603 Uses of 1-amino-3-(N,N-dimethylamino)-propylidene-1,1-bisphosphonic acid
08/12/2003US6605602 Method of treating BK virus nephropathy
08/12/2003US6605601 Hypotensive agents; cardiovascular disorders
1 ... 5379 5380 5381 5382 5383 5384 5385 5386 5387 5388 5389 5390 5391 5392 5393 5394 5395 5396 5397 5398 5399 ... 7860